Skip to main content

Reblozyl Prices, Coupons, Copay Cards & Patient Assistance

Reblozyl (luspatercept) is a member of the miscellaneous erythropoiesis agents drug class and is commonly used for Anemia, Beta Thalassemia, and Myelodysplastic Syndrome.

The cost for Reblozyl aamt 25 mg subcutaneous powder for injection is around $4,172 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Reblozyl prices

Subcutaneous Powder For Injection

aamt 25 mg

Reblozyl subcutaneous powder for injection

from $4,172.45

for 1 powder for injection

Quantity Per unit Price
1 $4,172.45 $4,172.45

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

aamt 75 mg

Reblozyl subcutaneous powder for injection

from $12,498.31

for 1 powder for injection

Quantity Per unit Price
1 $12,498.31 $12,498.31

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Reblozyl Coupons, Copay Cards and Rebates

Reblozyl offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Reblozyl BMS Oncology Co-pay Assistance Program

Eligible commercially insured patients' co-pay may be reduced to $0 per dose with savings of up to $10,000 per calendar year; enrollment period is 1 calendar year.

Applies to:
Reblozyl
Number of uses:
per prescription per calendar year

Form more information phone: 800-861-0048 or Visit website

Patient Assistance & Copay Programs for Reblozyl

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Reblozyl (luspatercept-aamt) Injection; Subcutaneous

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Reblozyl (luspatercept-aamt) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: Bristol Myers Squibb (BMS) Access Support

Eligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or Puerto Rico
  5. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please refer to the Enrollment Form to ensure the correct Fax number and address is used for your medication.
Applicable drugs:
  • Reblozyl (luspatercept-aamt) Injection; Subcutaneous

More information please phone: 800-861-0048 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.